ALNYLAM PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2010 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Alnylam Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2010 to Q2 2024.
  • Alnylam Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 26, 2024 was 128M shares, a 2.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 128M +3.38M +2.7% Jul 26, 2024 10-Q 2024-08-01
Q1 2024 126M +1.97M +1.58% Apr 26, 2024 10-Q 2024-05-02
Q4 2023 126M Feb 9, 2024 10-K 2024-02-15
Q3 2023 125M +2.46M +2% Oct 27, 2023 10-Q 2023-11-02
Q2 2023 125M +4.97M +4.14% Jul 28, 2023 10-Q 2023-08-03
Q1 2023 125M +3.71M +3.07% Apr 28, 2023 10-Q 2023-05-04
Q3 2022 123M +3.43M +2.87% Oct 21, 2022 10-Q 2022-10-27
Q2 2022 120M +1.18M +0.99% Jul 22, 2022 10-Q 2022-07-28
Q1 2022 121M +3.27M +2.78% Apr 22, 2022 10-Q 2022-04-28
Q4 2021 120M +3.21M +2.74% Feb 4, 2022 10-K 2022-02-10
Q3 2021 120M +3.42M +2.94% Oct 22, 2021 10-Q 2021-10-28
Q2 2021 119M +2.88M +2.48% Jul 30, 2021 10-Q 2021-08-03
Q1 2021 118M +2.73M +2.37% Apr 23, 2021 10-Q 2021-04-29
Q4 2020 117M +4.42M +3.92% Feb 5, 2021 10-K 2021-02-11
Q3 2020 116M +4.69M +4.21% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 116M +4.76M +4.28% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 115M +8.28M +7.77% Apr 30, 2020 10-Q 2020-05-06
Q4 2019 113M +6.33M +5.95% Feb 7, 2020 10-K 2020-02-13
Q3 2019 111M +10.5M +10.4% Oct 25, 2019 10-Q 2019-10-31
Q2 2019 111M +10.5M +10.5% Jul 31, 2019 10-Q 2019-08-06
Q1 2019 107M +6.01M +5.98% Apr 30, 2019 10-Q 2019-05-02
Q4 2018 106M +6.39M +6.4% Jan 31, 2019 10-K 2019-02-14
Q3 2018 101M +8.3M +8.95% Oct 31, 2018 10-Q 2018-11-07
Q2 2018 101M +8.93M +9.74% Jul 31, 2018 10-Q 2018-08-02
Q1 2018 101M +14.3M +16.6% Apr 30, 2018 10-Q 2018-05-04
Q4 2017 99.9M +13.9M +16.1% Jan 31, 2018 10-K 2018-02-15
Q3 2017 92.7M +6.92M +8.06% Oct 31, 2017 10-Q 2017-11-07
Q2 2017 91.7M +6.01M +7.01% Jul 31, 2017 10-Q 2017-08-09
Q1 2017 86.2M +630K +0.74% Apr 28, 2017 10-Q 2017-05-05
Q4 2016 86M +875K +1.03% Jan 31, 2017 10-K 2017-02-15
Q3 2016 85.8M +1.08M +1.27% Oct 31, 2016 10-Q 2016-11-03
Q2 2016 85.7M +1.11M +1.31% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 85.6M +1.28M +1.52% Apr 29, 2016 10-Q 2016-05-04
Q4 2015 85.1M +1.38M +1.65% Jan 29, 2016 10-K 2016-02-12
Q3 2015 84.7M +7.8M +10.1% Oct 30, 2015 10-Q 2015-11-09
Q2 2015 84.6M +8.26M +10.8% Jul 31, 2015 10-Q 2015-08-07
Q1 2015 84.3M +8.73M +11.6% Apr 30, 2015 10-Q 2015-05-08
Q4 2014 83.8M +19.8M +31% Jan 30, 2015 10-K 2015-02-13
Q3 2014 76.9M +13.5M +21.3% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 76.4M +13.4M +21.3% Jul 31, 2014 10-Q 2014-08-08
Q1 2014 75.6M +13.4M +21.5% Apr 30, 2014 10-Q 2014-05-09
Q4 2013 63.9M +2.05M +3.31% Jan 31, 2014 10-K 2014-02-20
Q3 2013 63.4M +11M +21% Oct 31, 2013 10-Q 2013-11-07
Q2 2013 63M +10.7M +20.5% Jul 31, 2013 10-Q 2013-08-09
Q1 2013 62.2M +10.2M +19.7% Apr 30, 2013 10-Q 2013-05-07
Q4 2012 61.9M +18.7M +43.2% Jan 31, 2013 10-K 2013-02-19
Q3 2012 52.4M +9.69M +22.7% Oct 31, 2012 10-Q 2012-11-05
Q2 2012 52.2M +9.59M +22.5% Jul 31, 2012 10-Q 2012-08-08
Q1 2012 51.9M +9.54M +22.5% Apr 30, 2012 10-Q 2012-05-03
Q4 2011 43.2M +865K +2.04% Jan 31, 2012 10-K 2012-02-13
Q3 2011 42.7M +527K +1.25% Oct 31, 2011 10-Q 2011-11-03
Q2 2011 42.7M +555K +1.32% Jul 29, 2011 10-Q 2011-08-03
Q1 2011 42.4M May 2, 2011 10-Q 2011-05-05
Q4 2010 42.3M Jan 31, 2011 10-K 2011-02-18
Q3 2010 42.2M Oct 29, 2010 10-Q 2010-11-04
Q2 2010 42.1M Jul 30, 2010 10-Q 2010-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.